Articles related to Clinical Pharmacology

The greatest method to guarantee the best possible patient care, according to leaders of specialty pharmacies housed in health systems, is to supply specialized pharmaceuticals through the framework of a health system. It may be debatable which paradigm—the conventional standalone specialty pharmacies or the integrated model of health systems—is the best. However, it cannot be denied that a growing proportion of medications on the market are being introduced as specialty drugs.

Despite sufficient resources available to help practitioners make the right decisions about prescribing nirmatrelvir-ritonavir to the patients who may benefit, there are, without a doubt, instances when not prescribing nirmatrelvir-ritonavir is completely justified.

FDA approved new indications for these drugs in July, include a Janus kinase inhibitor and a phosphodiesterase-4 inhibitor for use in dermatology, a carbonic anhydrase inhibitor for partial-onset seizures, and an expanded indication for the TKI crizotinib.

As use of gabapentin in the United States has been steadily increasing in recent years, researchers from the CDC have found that, among the 62,652 overdose deaths that occurred between 2019 and 2020, 58,362 of these cases had documented toxicology results.

The CDC has released updated guidelines for prescribing opioids. The newest guidelines focus on patient-centered decisions and reduce some limitations on prescribing that were put in place back in 2016. The updated guidance recognizes the ongoing increase in opioid-related deaths, but seeks to give physicians and patients more direction in managing individual therapy.